PDZK1IP1 and familial pancreatic carcinoma: To study the specific effect of MAP17 in pancreatic cancer, we overexpressed MAP17 in two different pancreatic cancer cell lines (PANC-1 and HPAF-II) using an empty vector as a negative control.